A phase I trial of ISIS GCGRRx in volunteers

Trial Profile

A phase I trial of ISIS GCGRRx in volunteers

Phase of Trial: Phase I

Latest Information Update: 10 Dec 2012

At a glance

  • Drugs IONIS-GCGRRx (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Dec 2012 Positive results were reported in an Isis Pharmaceuticals media release.
    • 07 Dec 2012 Status changed from recruiting to completed.
    • 04 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top